Quantedge Capital’s Meridian Bioscience Inc VIVO Stock Holding History

Quantedge Capital’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-96,000	Closed	-$3.19M	–	191
2022 Q4	$3.19M	Sell	96,000 -55,500	-37%	-$1.79M	1.07%	32
2022 Q3	$4.78M	Sell	151,500 -10,700	-7%	-$346K	1.47%	12
2022 Q2	$4.93M	Buy	162,200 +122,500	+309%	+$3.31M	0.99%	28
2022 Q1	$1.03M	Buy	+39,700	New	+$944K	0.3%	89

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Quantedge Capital's VIVO Position: Q1 2023 in Review

Quantedge Capital sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 96,000 shares — an estimated $3.19M sold.

Quantedge Capital first reported a position in VIVO in Q1 2022 and held it in 4 quarters. The position peaked at $4.93M in Q2 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Quantedge Capital reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Quantedge Capital sold 96,000 Meridian Bioscience Inc shares in Q1 2023, an estimated $3.19M.
Quantedge Capital first reported a position in Meridian Bioscience Inc in Q1 2022 and held it in 4 quarters.
Quantedge Capital's Meridian Bioscience Inc position peaked at $4.93M in Q2 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Quantedge Capital's 13F filing for Q1 2023, filed 12 May 2023.